{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:10:35Z","timestamp":1782969035500,"version":"3.54.5"},"reference-count":10,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Blood center organizations (BCOs) have traditionally offered two gender choices (male or female) on the donor history questionnaire (DHQ). Our BCO was one of the first in the United States to offer additional options on our DHQ to improve the experience for gender nonconforming donors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design and Methods<\/jats:title><jats:p>Three years of data were analyzed from all blood donation visits between March 2019 and March 2022. Donors were stratified by gender categories and generation as follows: Gen Z, Millennial, Gen X, Boomers, and Silent. First time donor status, donor deferrals and infectious disease rates were evaluated for each category.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Donor gender makeup included 127,072 (99.78%) Male\/Female (M\/F) and 282 (0.22%) Trans\/Other (T\/O) donors. The return rate for first\u2010time donors was 36.75% for M\/F donors compared to 33.84% for T\/O donors. The generational breakdown of our T\/O donors is 71.28% Gen Z, 21.99% Millennial, 3.19% Gen X, 3.55% Boomers and none from the Silent Generation. Comparing high risk DHQ deferrals, there were 719 (0.57%) M\/F deferrals and 18 (6.38%) T\/O deferrals. Disease marker testing resulted in 2314 (0.56%) deferrals of M\/F donors compared to 2 (0.41%) T\/O deferrals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Increased gender options on the DHQ allowing gender diverse self\u2010identification enhances inclusivity. Transgender and nonbinary individuals accounted for a minority of donors, most of whom are younger, and have a comparable return rate to M\/F donors. Shifts in donor policies can ensure inclusivity of this diverse population and provide an opportunity to expand the base of eligible donors.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.17446","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T15:14:29Z","timestamp":1685718869000},"page":"1284-1289","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Confronting the challenge of gender nonconforming donors: A blood center's three\u2010year experience"],"prefix":"10.1111","volume":"63","author":[{"given":"Vanessa","family":"Reynolds","sequence":"first","affiliation":[{"name":"Innovative Blood Resources Division of New York Blood Center, Physician Services  Saint Paul Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1309-9770","authenticated-orcid":false,"given":"Nancy L.","family":"Van Buren","sequence":"additional","affiliation":[{"name":"Innovative Blood Resources Division of New York Blood Center, Physician Services  Saint Paul Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3630-372X","authenticated-orcid":false,"given":"Jed B.","family":"Gorlin","sequence":"additional","affiliation":[{"name":"Innovative Blood Resources Division of New York Blood Center, Physician Services  Saint Paul Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15777"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13865"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15315"},{"key":"e_1_2_8_5_1","unstructured":"GLAAD Media Reference Guide Glossary of Terms \u2013 Transgender. [Accessed 2023 Feb 10]. Available from:https:\/\/www.glaad.org\/reference\/trans-terms"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13193"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.13192"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1217762\/v1"},{"key":"e_1_2_8_9_1","unstructured":"FDA Recommendations for Evaluating Donor Eligibility Using Individual Risk\u2010Based Question to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products. Draft Guidance for Industry. January 2023. [Accessed 7 March 2023]. Available from:https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/recommendations-evaluating-donor-eligibility-using-individual-risk-based-questions-reduce-risk-human"},{"key":"e_1_2_8_10_1","unstructured":"ADVANCE study (Assessing Donor Variability and New Concepts in Eligibility). [Accessed 2023 Feb 10]. Available from:https:\/\/advancestudy.org\/"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.17000"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.17446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T11:57:39Z","timestamp":1708430259000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.17446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1111\/trf.17446"],"URL":"https:\/\/doi.org\/10.1111\/trf.17446","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"assertion":[{"value":"2023-01-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}